At Linking Health International, we specialize in novel and special medications from overseas markets
Based in Hong Kong, we serve clients globally
We ensure the authenticity of our products through direct, bulk procurement
We offer cost-effective and affordable medication plans
For patients in mainland China seeking medical advice and medications from overseas
We offer a comprehensive network of pharmaceutical companies and a team of medical experts
We offer thousands of novel and special medications,directly to the patient
Ensuring timely delivery in sync with global market releases
About Linking Health International
Founded in 2020, Linking Health International is a burgeoning global health industry group based in Hong Kong, serving the mainland. Our direct operations include cross-border pharmaceutical retail, pharmaceutical manufacturing, healthcare services, integrated marketing for health media, nutritional supplement manufacturing and sales, and overseas services for medical enterprises.
Headquartered in Hong Kong,Linking Health International is a new retail platform specializing in novel and special overseas medications. We have established a direct supply system for source medications in multiple countries globally. We hold licenses for Chinese medicine wholesale (PW-2022-00066) and Western medicine wholesale (109/2A/2022) issued by the Hong Kong Department of Health, adhering to integrity and authenticity as our core principles.
Our self-operated pharmaceutical warehouse in Hong Kong covers over a hundred proprietary overseas oncology drugs, rare disease medications, and other novel and special medications, with the option to order thousands more. We focus on providing global consumers with fast, high-quality, and cost-effective medication purchasing services. Our supply chain includes international pharmaceutical procurement, logistics, customs, and insurance, partnering with quality pharmaceutical varieties from Europe, North America, South Asia, East Asia, Southeast Asia, and the Middle East. Our company has multiple advantageous overseas pharmaceutical varieties, leading in sales across our platform.
Our Commitment to Patients
We take responsibility for our patients seriously, strictly managing our supply chain from end to end, continuously improving service quality and efficiency.
Our Commitment to Patients
We take responsibility for our patients seriously, strictly managing our supply chain from end to end, continuously improving service quality and efficiency
Comprehensive Medication Selection
Our diverse procurement network ensures a complete range of medications
100% Authenticity Guarantee
Our products are regulated and guaranteed to be authentic
End-to-End Logistics
Efficient cross-border logistics ensure timely delivery
Dedicated Customer Service
Our 1V1 exclusive customer service is always ready to address your concerns promptly
Covering Over a Thousand Types of New Special Overseas Medicines
This includes original research and generic drugs
a focus on cancer medicines
rare disease drugs
men's and women's health medications
GLP-1 diabetes treatments
Cooperative Brands
We are committed to enhancing the accessibility of authentic new overseas medicines to Chinese patients, with a vision to improve their life span and quality. Our focus remains on benefiting patients.
With licenses for Chinese (PW-2022-00066) and Western (109/2A/2022) medicine wholesale
We are a Hong Kong Health Department authorized importer and exporter of new special medicines.
Being strategic partners with Eternal Asia, a state-owned A-share listed company
Established in 1997, Eternal Asia Supply Chain Management Ltd.(Eternal Asia) is a Fortune 500 company under the Shenzhen Investment Holdings Co., Ltd., China's first listed supply chain company (Stock Code 002183). It integrates supply chain platform services, brand marketing, digital business, and corporate investment, boasting nearly ten thousand employees. In 2022, the company achieved a business volume of over 110 billion yuan, ranking 193rd in the 2022 Fortune China 500.
More
Media Coverage
© 2023 灵景健康国际有限公司 版权所有 粤ICP备2021136778号-1 互联网药品信息许可证 (粤)-经营性-2022-0150
About Linking Health International